Atherosclerosis Immunoimaging by Positron Emission Tomography-Reference-Cited by-同舟云学术

Atherosclerosis Immunoimaging by Positron Emission Tomography

Published:2020-04 Issue:4 Volume:40 Page:865-873
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:ATVB

Author:

Pérez-Medina Carlos¹²,Fayad Zahi A.²,Mulder Willem J.M.²³

Affiliation:

1. From the Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain (C.P.-M.)

2. Icahn School of Medicine at Mount Sinai, New York (C.P.-M., Z.A.F., W.J.M.M.)

3. Eindhoven University of Technology, the Netherlands (W.J.M.M.).

Abstract

The immune system’s role in atherosclerosis has long been an important research topic and is increasingly investigated for therapeutic and diagnostic purposes. Therefore, noninvasive imaging of hematopoietic organs and immune cells will undoubtedly improve atherosclerosis phenotyping and serve as a monitoring method for immunotherapeutic treatments. Among the available imaging techniques, positron emission tomography’s unique features make it an ideal tool to quantitatively image the immune response in the context of atherosclerosis and afford reliable readouts to guide medical interventions in cardiovascular disease. Here, we summarize the state of the art in the field of atherosclerosis positron emission tomography immunoimaging and provide an outlook on current and future applications.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference61 articles.

1. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

2. Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

3. Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI

4. First Human Imaging Studies with the EXPLORER Total-Body PET Scanner*

5. Targeting the Immune System in Atherosclerosis

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Broad-Spectrum Nanobodies for the Therapy and Diagnosis of SARS-CoV-2 and Its Multiple Variants;Molecular Pharmaceutics;2024-06-26

2. Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall;International Journal of Molecular Sciences;2024-02-21

3. The Link Between Dysregulated Immunometabolism and Vascular Damage: Implications for the Development of Atherosclerosis in Systemic Lupus Erythematosus and Other Rheumatic Diseases;The Journal of Rheumatology;2024-01-15

4. Immunotherapy-Associated Atherosclerosis: A Comprehensive Review of Recent Findings and Implications for Future Research;Current Treatment Options in Cardiovascular Medicine;2023-12

5. Nanobodies as Diagnostic and Therapeutic Tools for Cardiovascular Diseases (CVDs);Pharmaceuticals;2023-06-09